Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
AbbVie Completes Acquisition of Landos Biopharma
04:05pm, Thursday, 23'rd May 2024
- Adds first-in-class investigational asset, NX-13, to AbbVie's pipeline with the potential to offer a novel approach to the treatment of ulcerative colitis (UC) and Crohn's disease (CD) NORTH CHI
3 Biotech Stocks to Buy on the Dip: May 2024
02:01pm, Thursday, 23'rd May 2024
Biotech is one of the most exciting industries to invest in right now. Companies have drugs on the market worth billions and continue to strive to produce the newest and best treatments in modern medi
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
10:46am, Thursday, 23'rd May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
A Must-Own Stock for Any Portfolio
08:42am, Wednesday, 22'nd May 2024
This company offers growth, high yield, and dividend growth.
Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel
08:00am, Wednesday, 22'nd May 2024
ATLANTA--(BUSINESS WIRE)---- $ABBV #Alzamend--Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel.
2 Billion More Reasons to Buy AbbVie Stock
06:45am, Wednesday, 22'nd May 2024
AbbVie is bolstering its psychiatry pipeline with an acquisition. The biotech it's acquiring is developing psychedelic-adjacent drugs.
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof
02:47pm, Monday, 20'th May 2024
Since 1928, there have been 25 bear markets, or declines in the S&P 500 of 20% or more, according to Yardeni Research. Market corrections have been far more common.
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
10:58am, Monday, 20'th May 2024
AbbVie's lead drug Humira lost its patent-protected market exclusivity in the U.S. last year. Despite shrinking Humira revenues, AbbVie's first-quarter sales grew thanks to more recently launched bloc
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
07:30am, Friday, 17'th May 2024
- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammator
7 Value Stocks to Buy and Hold for a Decade of Dominance
07:11am, Friday, 17'th May 2024
Finding equities with the potential for steady, long-term development is crucial. These seven prospects span a variety of industries and offer solid arguments for long-term investment.
Are You Looking for a High-Growth Dividend Stock?
12:45pm, Thursday, 16'th May 2024
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?
Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for May 2024
06:00am, Thursday, 16'th May 2024
What could be better than well-established retirement stocks to buy that you can trust? How about adding to that confidence level with the backing of Wall Street analysts.
AbbVie, Inc. (ABBV) Bank of America Health Care Conference Call Transcript
05:50pm, Wednesday, 15'th May 2024
AbbVie, Inc. (NYSE:ABBV ) Bank of America Health Care Conference Call May 15, 2024 1:40 PM ET Company Participants Robert Michael - CEO Roopal Thakkar - SVP, Chief Medical Officer, Global Therapeutics
2 Fortune 100 Best Co's To Work For Are Also Good To Own
03:37pm, Wednesday, 15'th May 2024
2 Fortune 100 Best Co's To Work For Are Also Good To Own
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
01:10pm, Tuesday, 14'th May 2024
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.
